Davide Martorana Selected Research

Davide Martorana Research Topics

Disease

6	Vasculitis (Vasculitides) 10/2022 - 09/2007
4	Churg-Strauss Syndrome (Allergic Angiitis) 10/2022 - 09/2007
4	Microscopic Polyangiitis 10/2022 - 07/2012
4	Retroperitoneal Fibrosis 03/2018 - 02/2006
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 10/2022 - 07/2012
3	Autoimmune Diseases (Autoimmune Disease) 11/2019 - 02/2006
3	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 04/2015 - 07/2012
2	Venous Thrombosis (Deep-Vein Thrombosis) 03/2018 - 01/2013
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2018 - 11/2013
2	Hemorrhage 01/2017 - 09/2007
2	Hypoxia (Hypoxemia) 12/2007 - 10/2006
1	Giant Cell Arteritis (Horton Disease) 05/2024
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2017
1	Factor VII Deficiency (Hypoproconvertinemia) 01/2017
1	Infections 11/2015
1	Breast Neoplasms (Breast Cancer) 06/2014
1	Neoplasms (Cancer) 06/2014
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 06/2014
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2014
1	Gastroenteritis 06/2014
1	Elephantiasis 06/2014
1	Ureteral Obstruction 01/2013
1	Skin Manifestations 05/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2011
1	Cognitive Dysfunction 05/2011
1	autosomal dominant familial Periodic fever 07/2010
1	Fever (Fevers) 07/2010
1	Glomerulonephritis 09/2007
1	Purpura 09/2007
1	Mononeuropathies (Mononeuritis Multiplex) 09/2007
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 10/2006
1	Aneurysm (Aneurysms) 08/2006
1	Atherosclerosis 08/2006
1	Atherosclerotic Plaque (Atheroma) 08/2006
1	Cataract (Cataracts) 10/2003
1	Age-Related Nuclear Cataract 10/2003

Drug/Important Bio-Agent (IBA)

7	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2022 - 09/2007
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2003
3	HLA-DQ Antigens (HLA-DQ)IBA 11/2019 - 05/2014
3	Myeloblastin (Proteinase 3)IBA 04/2015 - 07/2012
2	Peroxidase (Myeloperoxidase)IBA 10/2022 - 07/2012
2	Rituximab (Mabthera)FDA Link 01/2017 - 11/2013
2	HLA-DRB4 Chains (HLA DRB4)IBA 04/2015 - 09/2007
2	AutoantigensIBA 05/2014 - 07/2012
2	SteroidsIBA 11/2013 - 08/2006
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 08/2006 - 02/2006
1	Immunoglobulin G (IgG)IBA 03/2018
1	IgG Receptors (Fc gamma RI)IBA 01/2018
1	factor VII clotting antigenIBA 01/2017
1	Factor VII (Proconvertin)IBA 01/2017
1	VaccinesIBA 11/2015
1	Viral DNAIBA 11/2015
1	Glycoproteins (Glycoprotein)IBA 11/2015
1	HLA-DPw1 antigenIBA 04/2015
1	EnzymesIBA 06/2014
1	Semaphorins (Semaphorin)IBA 05/2014
1	HLA-DP Antigens (HLA-DP)IBA 05/2014
1	Calcineurin InhibitorsIBA 11/2013
1	Prednisone (Sone)FDA LinkGeneric 11/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Chemokine CCL26IBA 10/2011
1	CCR5 Receptors (CCR5 Receptor)IBA 06/2011
1	ApolipoproteinsIBA 05/2011
1	Apolipoproteins E (ApoE)IBA 05/2011
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2010
1	Type I Tumor Necrosis Factor ReceptorsIBA 07/2010
1	Small Interfering RNA (siRNA)IBA 12/2007
1	Interleukin-8 (Interleukin 8)IBA 12/2007
1	Interleukin-6 (Interleukin 6)IBA 10/2006
1	Insulin-Like Growth Factor Binding Protein 2IBA 10/2006
1	AutoantibodiesIBA 08/2006
1	AntigensIBA 08/2006
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2006
1	CeroidIBA 08/2006
1	LDL Lipoproteins (beta Lipoproteins)IBA 08/2006
1	C-Reactive ProteinIBA 02/2006
1	HLA-DRB1 Chains (HLA DRB1)IBA 02/2006
1	RNA (Ribonucleic Acid)IBA 10/2003
1	Messenger RNA (mRNA)IBA 10/2003

Therapy/Procedure

2	Therapeutics 11/2013 - 08/2006
1	Precision Medicine 05/2024
1	Conservative Treatment 01/2013
1	Lenses 10/2003
1	Capsulorhexis 10/2003